Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
77,353
-
Share change
-
+40,529
-
Total reported value
-
$577,000
-
Price per share
-
$7.46
-
Number of holders
-
9
-
Value change
-
+$332,000
-
Number of buys
-
6
-
Number of sells
-
3
Institutional Holders of VASCULAR BIOGENICS LTD - COM (VBLT) as of Q3 2015
As of 30 Sep 2015,
VASCULAR BIOGENICS LTD - COM (VBLT) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
77,353 shares.
The largest 9 holders included
A.R.T. Advisors, LLC, ELLINGTON MANAGEMENT GROUP LLC, KCG Holdings, Inc., ATHENA CAPITAL ADVISORS LLC, Creative Planning, Burt Wealth Advisors, AMERICAN INTERNATIONAL GROUP INC, DEUTSCHE BANK AG\, and MetLife Securities, Inc.
This page lists
9
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.